Certara Company Insiders
| CERT Stock | USD 9.51 0.01 0.11% |
Certara employs about 1.5 K people. The company is managed by 21 executives with a total tenure of roughly 3470 years, averaging almost 165.0 years of service per executive, having 70.81 employees per reported executive. Breaking down Certara's management performance can provide insight into the firm performance.
Certara Management Team Effectiveness
The company has return on total asset (ROA) of 0.0126 % which means that it generated a profit of $0.0126 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0103 %, meaning that it created $0.0103 on every $100 dollars invested by stockholders. Certara's management efficiency ratios could be used to measure how well Certara manages its routine affairs as well as how well it operates its assets and liabilities.The majority of Certara outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Certara to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Certara. Please pay attention to any change in the institutional holdings of Certara as this could imply that something significant has changed or is about to change at the company.
Certara Workforce Comparison
Certara is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 64,927. Certara holds roughly 1,487 in number of employees claiming about 2.29% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07. Certara Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Certara insiders, such as employees or executives, is commonly permitted as long as it does not rely on Certara's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Certara insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jon Resnick over two weeks ago Insider Trading | ||
William Feehery over six months ago Disposition of 33220 shares by William Feehery of Certara subject to Rule 16b-3 | ||
Daniel Corcoran over six months ago Disposition of 2298 shares by Daniel Corcoran of Certara at 11.4 subject to Rule 16b-3 | ||
Walsh Matthew M over six months ago Acquisition by Walsh Matthew M of 15757 shares of Certara subject to Rule 16b-3 | ||
William Feehery over six months ago Acquisition by William Feehery of 187144 shares of Certara subject to Rule 16b-3 | ||
Cashman James E Iii over six months ago Disposition of 8663 shares by Cashman James E Iii of Certara subject to Rule 16b-3 | ||
William Feehery over six months ago Disposition of 36580 shares by William Feehery of Certara subject to Rule 16b-3 | ||
William Feehery over six months ago Disposition of 36580 shares by William Feehery of Certara subject to Rule 16b-3 |
Certara Notable Stakeholders
A Certara stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Certara often face trade-offs trying to please all of them. Certara's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Certara's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jon Resnick | CEO Director | Profile | |
| Robert Aspbury | President Technologies | Profile | |
| Patrick PharmD | President Solutions | Profile | |
| Leif Pedersen | President Officer | Profile | |
| Richard Traynor | General VP | Profile | |
| PharmD Bois | Head Advisor | Profile | |
| Frederic Bois | Head Advisor | Profile | |
| Hannah Jones | Senior Services | Profile | |
| Sheila MBA | Chief Officer | Profile | |
| Ron DiSantis | Senior Development | Profile | |
| David Mitchell | Senior Engagement | Profile | |
| William Feehery | CEO Director | Profile | |
| John III | Chief Officer | Profile | |
| Max Kanevsky | Chief Officer | Profile | |
| Andrew Schemick | Chief Officer | Profile | |
| Rona Anhalt | Chief Officer | Profile | |
| Nicolette Sherman | Chief Officer | Profile | |
| Jaap Mandema | Chief Officer | Profile | |
| Christopher Bouton | Chief Officer | Profile | |
| Daniel Corcoran | Senior Counsel | Profile |
About Certara Management Performance
The success or failure of an entity such as Certara often depends on how effective the management is. Certara management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Certara management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Certara management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. Certara operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1054 people.
Please note, the imprecision that can be found in Certara's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Certara. Check Certara's Beneish M Score to see the likelihood of Certara's management manipulating its earnings.
Certara Workforce Analysis
Traditionally, organizations such as Certara use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Certara within its industry.Certara Manpower Efficiency
Return on Certara Manpower
| Revenue Per Employee | 259K | |
| Revenue Per Executive | 18.3M | |
| Net Loss Per Employee | 8.1K | |
| Net Loss Per Executive | 573.9K | |
| Working Capital Per Employee | 110.8K | |
| Working Capital Per Executive | 7.8M |
Additional Tools for Certara Stock Analysis
When running Certara's price analysis, check to measure Certara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Certara is operating at the current time. Most of Certara's value examination focuses on studying past and present price action to predict the probability of Certara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Certara's price. Additionally, you may evaluate how the addition of Certara to your portfolios can decrease your overall portfolio volatility.